Colin Palmer

Title: Colin Palmer: Innovator in Dermatological Research

Introduction

Colin Palmer is a notable inventor based in Dundee, GB. He has made significant contributions to the field of dermatological research, particularly in the treatment of inflammatory skin conditions such as psoriasis. His innovative work has led to the development of methods that utilize PPAR delta and its antagonists.

Latest Patents

Colin Palmer holds a patent titled "Methods concerning PPAR delta and antagonists thereof." This patent focuses on non-human animals that overexpress PPAR delta or express transgenic PPAR delta as models for inflammatory skin conditions. The research highlights the potential for screening test substances to assess their suitability for treating conditions like psoriasis. Notably, the compound Methyl 3-({[2-(methoxy)-4-phenyl]amino}sulfonyl)-2-thiophenecarboxylate can be administered topically for the prevention or treatment of psoriasis.

Career Highlights

Colin Palmer is affiliated with the University Court of the University of Dundee, where he conducts his research. His work has garnered attention for its potential impact on the treatment of skin conditions, showcasing his dedication to advancing medical science.

Collaborations

Colin collaborates with esteemed colleagues, including John Foerster and Nainamalai Sitherswaran, to further his research endeavors. Their combined expertise contributes to the innovative approaches being developed in the field.

Conclusion

Colin Palmer's contributions to dermatological research through his patent and collaborations highlight his role as an innovator in the field. His work promises to enhance treatment options for inflammatory skin conditions, making a significant impact on patient care.